Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Resiliency Training for Adults With Neurofibromatosis Via Live Videoconferencing

NCT03406208 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT03406208
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03406208 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Resiliency Training for Adults With Neurofibromatosis Via Live Videoconferencing
Lead sponsor
Massachusetts General Hospital
Phase
Not applicable
Overall status
Completed
Start date
October 1, 2017
Completion date
February 28, 2022
Enrollment
228 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neurofibromatoses, neurofibromatosis 1, neurofibromatosis 2, schwannomatosis